Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome

NCT05658692 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.

NCT NCT05658692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05658692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Phase 4
Overall status
Unknown status
Start date
October 1, 2022
Completion date
December 31, 2023
Enrollment
1,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome